PCV15 and PCV21 and GSK’s Synflorix totaling a combined $7.8 billion in global pneumococcal vaccine sales in 2024 (approximately 82%, 14% and 4%, of such sales for these three products ...

The acquisition of the vaccines business of Novartis provides ... and disease caused by Haemophilus influenzae type b; launched Synflorix against pneumococcal diseases and acute otitis media ...

Concerned that the nation’s health leadership is casting unfounded doubt on the safety of well-studied vaccines and may take action to curb their use, a group of public health experts is working ...

Large and mid-cap vaccine makers are, as of now, unworried about their 2025 pipelines in the face of research funding declines by the Trump administration and a drop in biotech funding.

She also receives funding from the Canadian Institutes of Health Research and the Fonds de recherche du Québec to conduct research on vaccine acceptance. Janice E. Graham receives funding from ...

Clinical trials to test vaccine against Alzheimer's-promoting tau protein Date: April 23, 2025 Source: University of New Mexico Health Sciences Center Summary: Researchers hope to launch human ...

As winter turned to spring in early 2020, Laura Davis and Tjardus Greidanus were working on a film about vaccines. They were focused on the increasingly politicized debate around them, especially ...

A measles outbreak involving hundreds of people across the country has put a spotlight on the role of vaccines in treating preventable diseases—especially as childhood vaccination rates have ...